Bifunctional agents for imaging and therapy

Methods in Molecular Biology

Volumn 635, Issue , 2010, Pages 223-259

  Pandey, Ravindra K ^a   James, Nadine S ^a   Chen, Yihui ^a,b   Missert, Joseph ^a   Sajjad, Munawar ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

field of view (FOV); food and drug administration (FDA); magnetic resonance imaging (MRI); near infrared (NIR); Photodynamic therapy (PDT); photosensitizers (PS); positron emission tomography (PET)

Indexed keywords

DIAGNOSTIC AGENT; PHOTOSENSITIZING AGENT;

ANIMAL; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; METHODOLOGY; MOUSE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOCHEMOTHERAPY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SPECTROFLUOROMETRY; TREATMENT OUTCOME;

ANIMALS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POSITRON-EMISSION TOMOGRAPHY; SPECTROMETRY, FLUORESCENCE; TREATMENT OUTCOME;

EID: 77956403158     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-697-9_16     Document Type: Article

References (109)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. (1998) Photodynamic therapy. J Natl Cancer Inst, 90, 889-905. (Pubitemid 28304157)
2. Jori, G. (2004) Photodynamic therapy: basic and preclinical aspects. In: Horspool, W. and Francesco, L. (eds.) CRC Handbook of Organic Photochemistry and Photobiology. Boca Raton: CRC Press, Chapter 146.
3. Kessel, D. (2004) Delivery of photosensitizing agents. Adv. Drug Delivery Rev, 56(1), 7-8. (Pubitemid 38045420)
4. Dolmans, D. E. J. G., Fukumura, D., and Jain, R. K. (2003) Photodynamic therapy for cancer. Nat Rev Cancer, 3(5), 380.
5. Pandey, R. K. and Zheng, G. (2000) Porphyrins as photosensitizers in photodynamic therapy. Porphyrin Handb, 6, 157-230. and the references therein.
6. Pandey, R. K., James, N., Chen, Y., and Dobhal, M. P. (2008) Topics in Heterocyclic Chemistry. Berlin/Heidelberg: Springer, Vol. 14/2008, 41-74.
7. Henderson, B. W. and Dougherty, T. J. (1992) How does photodynamic therapy work? Photochem Photobiol, 55, 145-157.
8. Sternberg, E. D., Dolphin, D., and Bruckner, C. (1998) Porphyrin-based photosensitizers for the use in photodynamic therapy. Tetrahedron, 54(17), 4151-4202. (Pubitemid 28162666)
9. Sherman, W. M., Allen, C. M., and van Lier, J. E. (2000) Role of activated oxygen species in photodynamic therapy. Methods Enzymol, 319, 376-386.
10. MacDonald, I. and Dougherty, T. J. (2001) Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines, 5(105), 2001-2011.
11. Weishaupt, K. R., Gomer, C. J., and Dougherty, T. J. (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of murine tumor. Cancer Res, 90, 889-899.
12. Ali, H. and Van Lier, J. E. (1999) Metal complexes as photo-and radiosensitizers. Chem Rev (Washington, DC), 99, 2379-2450.
13. Bonnett, R. (1995) Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev, 24, 19-33.
14. Chen, Y., Sumlin, A., Morgan, J., Gryshuk, A., Oseroff, A., Henderson, B. W., Dougherty, T. J., and Pandey, R. K. (2004) Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimides. J Med Chem, 47, 4814-4817. (Pubitemid 39238255)
15. Ethirajan, M., Saenz, C., Gupta, A., Dobhal Mahabeer, P., and Pandey Ravindra, K. (2008) In: Hamblin, M. R. and Mroz, P. (eds.), Photosynsitizers for Photodynamic Therapy and Imaging: Advances in Photodynamic Therapy. Boston: Artech House Series.
16. Kessel, D. (2004) Delivery of photosensitizing agents. Adv Drug Delivery Rev, 56, 7-8. (Pubitemid 38045420)
17. Oleinick, N. L., Morris, R. L., and Belichenko, I. (2002) The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci, 1, 1-21. (Pubitemid 37069701)
18. Pandey, R. K., Goswami, L. N., Chen, Y., Gryshuk, A., Missert, J. R., Oseroff, A., and Dougherty, T. J. (2006) Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers Surg Med, 38, 445-467.
19. Pandey, R. K. and Herman, C. K. (1998) Shedding some light on tumors. Chem Ind (London), 739-743.
20. Brown, S. B., Brown, E. A., and Walker, I. (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol, 5, 497-508. (Pubitemid 39069400)
21. Fingar, V. H., Wieman, J., Wiehle, S. A., and Cerrito, P. B. (1992) The role of microvasulature damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res, 53, 4914-4924.
22. Fingar, V. H., Wieman, T. J., Karavolos, P. S., Doak, K. W., Ouellet, R., and van Lier, J. E. (1993) The effects of photodynamic therapy using different substituted phthalocyanines on vessel constriction, vessel leakage and tumor response. Photochem Photobiol, 58, 251.
23. Pandey, R. K., Sumlin, A. B., Constantine, S., Aoudia, M., Potter, W. R., Bellnier, D. A., Henderson, B.W., Rodgers, M. A., Smith, K. M., and Dougherty, T. J. (1996) Alkyl ether analogs of chlorophyll-a derivatives, Part 1: synthesis, photophysical properties and photodynamic efficacy. Photochem Photobiol, 64, 194-204. (Pubitemid 26350479)
24. Tarantola, R. M., Law, J. C., Recchia, F. M., Sternberg, P., Jr., and Agarwal, A. (2008) Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy. Lasers Surg Med, 40, 671-675.
25. Betz, C. S., Rauschning, W., Stranadko, E. P., Riabov, M. V., Albrecht, V., Nifantiev, N. E., and Hopper, C. (2008) Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas. Lasers Surg Med, 40, 300-311. (Pubitemid 351920379)
26. Berkovitch, G., Doron, D., Nudelman, A., Malik, Z., and Rephaeli, A. (2008) Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation. J Med Chem, 51, 7356-7369.
27. Ohshiro, T., Nakajima, T., Sasaki, K., Fujii, S., and Taniguchi, Y. (2008) Photodynamic therapy with Talaporfin sodium for capillary hemangioma in a chicken comb model. Laser Surg Med, Suppl 20, Meeting Abstract, 339, 102.
28. Woodhams Josephine, H., MacRobert Alexander, J., Novelli, M., and Bown Stephen, G. (2006) Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours. Int J Can (Journal international du cancer), 118, 477-482. (Pubitemid 41779090)
29. Pandey, R. K. et al. Unpublished results.
30. Ke, M. S., Xue, L. -y, Feyes, D. K., Azizuddin, K., Baron, E. D., McCormick, T. S., Mukhtar, H., Panneerselvam, A., Schluchter, M. D., Cooper, K. D. et al. (2008) Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. Photochem Photobiol, 84, 407-414. (Pubitemid 351421393)
31. Taquet, J. -p., Frochot, C., Manneville, V. and Barberi-Heyob, M. (2007) Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy. Curr Med Chem, 14, 1673-1687. (Pubitemid 47010155)
32. Milgrom, L. R. (2008) Towards recombinant antibody-fragment targeted photodynamic therapy. Sci Prog, 91, 241-263.
33. Chen, B., Pogue, B. W., Hoopes, P. J., and Hasan, T. (2006) Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr, 16, 279-305.
34. Henry, J. M. and Isaacs, J. T. (1989) Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy. J Urol, 142, 165-170. (Pubitemid 19184031)
35. Urizzi, P., Allen, C. M., Langlois, R., Ouellet, R., La Madeleine, C., and Van Lier, J. E. (2001) Low-density lipoprotein-bound aluminum sulfophthalocyanine: targeting tumor cells for photodynamic therapy. J Porphyr Phthalocyanines, 5, 154-160. (Pubitemid 32125236)
36. Henderson, B. W., Bellnier, D. A., Greco, W. R., Sharma, A., Pandey, R. K., Vaughan, L. A., Weishaupt, K. R., and Dougherty, T. J. (1997) An in vivo quantitative structureactivity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res, 57, 4000-4007. (Pubitemid 27427689)
37. Raab, O. (1900) Action of fluorescent materials on infusorial substances. Zeitschrift fuer Biologie (Munich), 39, 524-546.
38. Winkelman, J. and Rasmussen-Taxdal, D. S. (1960) Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration. Bull Johns Hopkins Hosp, 107, 228-233.
39. Lipson, R. L. and Baldes, E. J. (1960) The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol, 82, 508-516.
40. Dougherty, T. J., Grindey, G. B., Fiel, R., Weishaupt, K. R., and Boyle, D. G. (1975) Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst, 55, 115-121.
41. Dougherty, T. J., Grindley, G. B., and Weishaupt, K. R. (1975) Photoradiation therapy of animal tumors. Proc Am Assoc Cancer Res, 16, 29-29.
42. Yumita, N., Han, Q. -S., Kitazumi, I., and Umemura, S.-i. (2008) Sonodynamicallyinduced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6. Cancer Sci, 99, 166-172. (Pubitemid 350239046)
43. Gurfinkel, M., Thompson, A. B., Ralston, W., Troy, T. L., Moore, A. L., Moore, T. A., Gust, J. D., Tatman, D., Reynolds, J. S., Muggenburg, B. et al. (2000) Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study. Photochem Photobiol, 72, 94-102.
44. Foster, A. E., Kwon, S., Ke, S., Lu, A., Eldin, K., Sevick-Muraca, E., and Rooney, C. M. (2008) In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl Opt, 47, 5944-5952.
45. Poellinger, A., Martin Jan, C., Ponder Steven, L., Freund, T., Hamm, B., Bick, U., and Diekmann, F. (2008) Near-infrared laser computed tomography of the breast first clinical experience. Acad Radiol, 15, 1545-1553.
46. Hawrysz, D. J. and Sevick-Muraca, E. M. (2000) Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia (New York, NY), 2, 388-417. (Pubitemid 32044786)
47. Mahmood, U., Tung, C. -H., Tang, Y., and Weissleder, R. (2002) Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology, 224, 446-451. (Pubitemid 34809126)
48. Dougherty, T. J. and Levy, J. G. (2003) Photodynamic therapy (PDT) and clinical applications. Biomed Photonics Handb, 38/ 31-38/16.
49. Henderson, B. W. and Miller, A. C. (1986) Effects of the scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res, 108, 196.
50. Chin, W. W. L., Heng, P. W. S., and Olivo, M. (2007) Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts. BMC Pharmacol, 7, 15.
51. Chin, W. W. L., Heng, P. W. S., Thong, P. S. P., Bhuvaneswari, R., Hirt, W., Kuenzel, S., Soo, K. C., and Olivo, M. (2008) Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. Euro J Pharm Biopharma, 69, 1083-1093.
52. Pandey, R. K. et al. Unpublished results.
53. Chin, W. W. L., Lau, W. K. O., Heng, P. W. S., Bhuvaneswari, R., and Olivo, M. (2006) Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone. J Photochem Photobio B, Biol, 84, 103-110.
54. Jiang, F. -L., Wong, W. -K., Zhu, X. -J., Zhou, G. -J., Wong, W. -Y., Wu, P. -L., Tam, H. -L., Cheah, K. -W., Ye, C., and Liu, Y. (2007) Synthesis, characterization, and photophysical properties of some heterodimetallic bisporphyrins of ytterbium and transition metals - enhancement and lifetime extension of Yb3+ emission by transition-metal porphyrin sensitization. Euro J Inorg Chem, 3365-3374.
55. Gravier, J., Schneider, R., Frochot, C., Bastogne, T., Schmitt, F., Didelon, J., Guillemin, F., and Barberi-Heyob, M. (2008) Improvement of metatetra( hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies. J Med Chem, 51(13), 3867-3877. (Pubitemid 351956516)
56. Li, G., Slansky, A., Dobhal, M. P., Goswami, L. N., Graham, A., Chen, Y., Kanter, P., Alberico, R. A., Spernyak, J., Morgan, J. et al. (2005) Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjug Chem, 16, 32-42. (Pubitemid 40129675)
57. Liu, J., Ohta, S. -I., Sonoda, A., Yamada, M., Yamamoto, M., Nitta, N., Murata, K., and Tabata, Y. (2007) Preparation of PEGconjugated fullerene containing Gd3+ ions for photodynamic therapy. J Control Release, 117, 104-110. (Pubitemid 46164862)
58. Chang, T. C., Chang, C. -C., Kang, C. -C., Chen, C. -T., and Lin, Y. -C. (2007) A new BMVC-porphyrin binary photosensitizer for PDT selectivity. Mol Cancer Ther, 6, 3526S.
59. Chen, Y., Gryshuk, A., Achilefu, S., Ohulchansky, T., Potter, W., Zhong, T., Morgan, J., Chance, B., Prasad, P. N., Henderson, B. W. et al. (2005) A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjug Chem, 16, 1264-1274. (Pubitemid 41368130)
60. Chen, Y., Ohkubo, K., Zhang, M., Wenbo, E., Liu, W., Pandey, S. K., Ciesielski, M., Baumann, H., Erin, T., Fukuzumi, S. et al. (2007) Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy. Photochem Photobiol Sci, 6, 1257-1267. (Pubitemid 350191110)
61. Isakau, H. A., Parkhats, M. V., Knyukshto, V. N., Dzhagarov, B. M., Petrov, E. P., and Petrov, P. T. (2008) Toward understanding the high PDT efficacy of chlorin e6-polyvinylpyrrolidone formulations: photophysical and molecular aspects of photosensitizer-polymer interaction in vitro. J Photochem Photobiol B, Biol, 92, 165-174.
62. Boisbrun, M., Vanderesse, R., Engrand, P., Olie, A., Hupont, S., Regnouf-de-Vains, J. -B., and Frochot, C. (2008) Design and photophysical properties of new RGD targeted tetraphenylchlorins and porphyrins. Tetrahedron, 64, 3494-3504.
63. Thomas, N., Tirand, L., Chatelut, E., Plenat, F., Frochot, C., Dodeller, M., Guillemin, F., and Barberi-Heyob, M. (2008) Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma bearing nude mice. Photochem Photobiol Sci, 7(4), 433-441. (Pubitemid 351490307)
64. Li, Y., Jang, W. -D., Nishiyama, N., Kishimura, A., Kawauchi, S., Morimoto, Y., Miake, S., Yamashita, T., Kikuchi, M., Aida, T. et al. (2007) Dendrimer generation effects on photodynamic efficacy of dendrimer porphyrins and dendrimer-loaded supramolecular nanocarriers. Chem Mater, 19, 5557-5562. (Pubitemid 350150581)
65. Pandey, S. K., Gryshuk, A. L., Sajjad, M., Zheng, X., Chen, Y., Abouzeid, M. M., Morgan, J., Charamisinau, I., Nabi, H. A., Oseroff, A. et al. (2005) Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach. J Med Chem, 48, 6286-6295. (Pubitemid 41428983)
66. Pandey, S. K., Sajjad, M., Chen, Y., Zheng, X., Yao, R., Missert, J. R., Batt, C., Nabi, H. A., Oseroff, A. R., and Pandey, R. K. (2009) Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I-labeled methyl-3-(1-iodobenzyloxyethyl)pyropheophorbide-a vs the corresponding glucose and galactose conjugates. J Med Chem, 52, 445-455.
67. Pandey, S. K., Sajjad, M., Chen, Y., Pandey, A., Missert, J. R., Batt, C., Yao, R., Oseroff, A. R., and Pandey, R. K. (2009) Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging ability. Bioconjug Chem, 20(2), 274-282.
68. Kang, C. -C., Chen, C. -T., Cho, C. -C., Lin, Y. -C., Chang, C. -C., and Chang, T.-C. (2008) A dual selective antitumor agent and fluorescence probe: the binary BMVCporphyrin photosensitizer. ChemMedChem, 3, 725-728.
69. Zheng, G., Graham, A., Shibata, M., Missert, J. R., Oseroff, A. R., Dougherty, T. J., and Pandey, R. K. (2001) Synthesis of beta -galactose-conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy. J Org Chem, 66, 8709-8716. (Pubitemid 34042233)
70. Li, G., Pandey, S. K., Graham, A., Dobhal, M. P., Mehta, R., Chen, Y., Gryshuk, A., Rittenhouse-Olson, K., Oseroff, A., and Pandey, R. K. (2004) Functionalization of OEP-based benzochlorins to develop carbohydrate-conjugated photosensitizers. Attempt to target beta -galactosiderecognized proteins. J Org Chem, 69, 158-172. (Pubitemid 38040821)
71. Stefflova, K., Chen, J., and Zheng, G. (2007) Killer beacons for combined cancer imaging and therapy. Curr Med Chem, 14, 2110-2125. (Pubitemid 47578152)
72. Stefflova, K., Li, H., Chen, J., and Zheng, G. (2007) Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjug Chem, 18, 379-388. (Pubitemid 46493508)
73. Massoud, T. F. and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev, 17, 545-580. (Pubitemid 36307540)
74. Chance, B. (1998) Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation. Ann N Y Acad Sci, 838, 29-45. (Pubitemid 28127634)
75. Chance, B., Cope, M., Gratton, E., Ramanujam, N., and Tromberg, B. (1998) Phase measurement of light absorption and scatter in human tissue. Rev Sci Instrum, 69, 3457-3481. (Pubitemid 129708721)
76. Choy, G., Choyke, P., and Libutti, S. K. (2003) Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging, 2, 303-312.
77. Achilefu, S., Dorshow, R. B., Bugaj, J. E., and Rajagopalan, R. (2000) Novel receptortargeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol, 35, 479-485. (Pubitemid 30622015)
78. Choi, H., Choi Seok, R., Zhou, R., Kung Hank, F., and Chen, I. W. (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol, 11, 996-1004. (Pubitemid 39220809)
79. Gao, X., Cui, Y., Levenson Richard, M., Chung Leland, W. K., and Nie, S. (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 22, 969-976. (Pubitemid 39014473)
80. Kelly, K., Alencar, H., Funovics, M., Mahmood, U., and Weissleder, R. (2004) Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res, 64, 6247-6251. (Pubitemid 39129427)
81. Sevick-Muraca, E. M., Godavarty, A., Houston, J. P., Thompson, A. B., and Roy, R. (2003) Near-infrared imaging with fluorescent contrast agents. Handb Biomed Fluoresc, 445-527.
82. Bouteiller, C., Clave, G., Bernardin, A., Chipon, B., Massonneau, M., Renard, P. -Y., and Romieu, A. (2007) Novel water-soluble near-infrared cyanine dyes: synthesis, spectral properties, and use in the preparation of internally quenched fluorescent probes. Bioconjug Chem, 18, 1303-1317. (Pubitemid 47122654)
83. Weissleder, R. and Ntziachristos, V. (2003) Shedding light onto live molecular targets. Nat Med (New York, NY, US), 9, 123-128. (Pubitemid 36098273)
84. Frangioni, J. V. (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol, 7, 626-634. (Pubitemid 37315800)
85. Klohs, J., Wunder, A., and Licha, K. (2008) Near-infrared fluorescent probes for imaging vascular pathophysiology. Basic Res Cardiol, 103, 144-151. (Pubitemid 351356756)
86. Ntziachristos, V. (2006) Fluorescence molecular imaging. Ann Rev Biomed Eng, 8, 1-33. (Pubitemid 44314811)
87. Sevick-Muraca, E. M., Kuwana, E., Godavatry, A., Houston, J. P., Thompson, J. P., and Roy, R. (2000) Near infra-red fluorescence imaging and spectroscopy in random media and tissues. In: Vo-Dinh, T. (ed.) Biomedical Photonics. Boca Raton: CRC Press.
88. Stranc, M. F., Sowa, M. G., Abdulrauf, B., and Mantsch, H. H. (1998) Assessment of tissue viability using near-infrared spectroscopy. Br J Plast Surg, 51, 210-217. (Pubitemid 28200957)
89. Klohs, J., Graefe, M., Graf, K., Steinbrink, J., Dietrich, T., Stibenz, D., Bahmani, P., Kronenberg, G., Harms, C., Endres, M. et al. (2008) In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke, 39, 2845-2852.
90. James, N. S., Goswami, L. N., Chen, Y., Sunar, U., Ohulchansky, T., and Pandey, R. K. Versatile Cyanine Dye Based Compounds for Tumor Imaging and Photodynamic Therapy. International Conference of Porphyrins and Phthalocyanines (ICPP-5),Moscow, July 2008.
91. Hilgenbrink, A. R. and Low, P. S. (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci, 94, 2135-2146. (Pubitemid 41665275)
92. Low, P. S., Henne, W. A., and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res, 41, 120-129.
93. Lu, Y. and Low, P. S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Delivery Rev, 54, 675-693. (Pubitemid 35247522)
94. Leamon, C. P. and Low, P. S. (2001) Folatemediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today, 6, 44-51. (Pubitemid 32156966)
95. Salazar, M. D. A. and Ratnam, M. (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev, 26, 141-152. (Pubitemid 46452188)
96. Mueller, C., Schibli, R., Krenning, E. P., and de Jong, M. (2008) Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer. J Nucl Med, 49, 623-629. (Pubitemid 351520611)
97. Sega, E. I. and Low, P. S. (2008) Tumor detection using folate receptortargeted imaging agents. Cancer Metastasis Rev, 27, 655-664.
98. Schneider, R., Schmitt, F., Frochot, C., Fort, Y., Lourette, N., Guillemin, F., Mueller, J.-F., and Barberi-Heyob, M. (2005) Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorg Med Chem, 13, 2799-2808. (Pubitemid 40387490)
99. Hofmeister, V., Schrama, D., and Becker, J. C. (2007) Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother, 57, 1-17.
100. Lo, P. -C., Chen, J., Stefflova, K., Warren, M. S., Navab, R., Bandarchi, B., Mullins, S., Tsao, M., Cheng, J. D., and Zheng, G. (2009) Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J Med Chem, 52, 358-368.
101. Nestle, U., Weber, W., Hentschel, M., and Grosu, A. -L. (2009) Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol, 54, R1-R25.
102. Magne, N., Chargari, C., Vicenzi, L., Gillion, N., Messai, T., Magne, J., Bonardel, G., and Haie-Meder, C. (2008) New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev, 34, 671-681.
103. Verel, I., Visser Gerard, W. M., and van Dongen Guus, A. (2005) The promise of immuno-PET in radioimmunotherapy. J Nucl Med: official publication, Society of Nuclear Medicine, 46(Suppl 1), 164S-171S. (Pubitemid 47619032)
104. Laville, I., Pigaglio, S., Blais, J. -C., Doz, F., Loock, B., Maillard, P., Grierson David, S., and Blais, J. (2006) Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells. J Med Chem, 49, 2558-2567.
105. Zhang, M., Zhang, Z., Blessington, D., Li, H., Busch, T. M., Madrak, V., Miles, J., Chance, B., Glickson, J. D., and Zheng, G. (2003) Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem, 14, 709-714. (Pubitemid 36875429)
106. Zhang, X., Morgan, J., Pandey, S. K., Chen, Y., Tracy, E., Baumann, H., Missert, J. R., Batt, C., Jackson, J., Bellnier, D. A., Henderson, B. W., and Pandey, R. K. (2009) Conjugation of HPPH to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. J Med Chem, 52, 4306-4318.
107. Munoz, A. and Castillo, M. (2008) Indications for adult and pediatric magnetic resonance imaging gadolinium-enhanced cisternography and myelography: experience and review of the literature. Curr Med Imaging Rev, 4, 170-180.
108. Caravan, P., Ellison, J. J., McMurry, T. J., and Lauffer, R. B. (1999) Gadolinium (III) chelates as MRI contrast agents: structure, dynamics and applications. Chem Rev, 99, 2293-2352. (Pubitemid 30498114)
109. Hueber, M. M., Staubli, A. B., Kustedjo, K., Gray, M. H. B., Shih, J., Fraser, S. E., Jacobs, R. E., and Meade, T. J. (1998) Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem, 9, 242-249. (Pubitemid 28147142)